Ezzat Elhassadi

5PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2026
SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.

|May 30, 2026
Genomic and clinical determinants of outcome in Irish AML: a real-world analysis (2007-2025), single centre experience.

|May 07, 2021
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.

Alexandros Rampotas, Matthew R Wilson, Oliver Lomas

|Apr 12, 2018
Durable treatment response of relapsing CNS plasmacytoma using intrathecal chemotherapy, radiotherapy, and Daratumumab.

Ezzat Elhassadi, Maurice Murphy, Dayle Hacking

|Oct 24, 2017
Cutaneous Vasculitis: An Unusual Presentation of a Biclonal Nodal Plasma Cell Dyscrasia.

D Swan, M Murphy, E Elhassadi

Pageof 1

Frequent Collaborators

1 joint publications

D Swan

1 joint publications

Alexandros Rampotas

1 joint publications

Matthew R Wilson

1 joint publications

Oliver Lomas